Miromatrix Medical Inc.
NASDAQ:MIRO
Overview | Financials
Company Name | Miromatrix Medical Inc. |
Symbol | MIRO |
Currency | USD |
Price | 3.39 |
Market Cap | 92,951,088 |
Dividend Yield | 0% |
52-week-range | 0.906 - 4.35 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Jeffrey James Ross Ph.D. |
Website | https://www.miromatrix.com |
An error occurred while fetching data.
About Miromatrix Medical Inc.
Miromatrix Medical Inc., a life sciences company, develops a novel technology for bioengineering fully transplantable organs. Its proprietary technology is a platform that uses a two-step method of decellularization and recellularization designed to remove the porcine cells from the organs obtained from pigs and replace them with unmodified human cells.
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD